Published December 9, 2015 in The Baltimore Sun.

The University of Maryland, Baltimore has given a Baltimore-based biotech company worldwide, exclusive licensing rights to the university’s patents and technology to develop a faster, cheaper way to identify dangerous pathogens, University of Maryland Ventures said Wednesday. Read full article here: The Baltimore Sun.

[Similar articles were published December 8, 2015 in Daily Record, Pharmavoice,, and]